MAPT and cutaneous mastocytosis: Also, increased CSF levels of tau were associated with long-term neurological and cognitive deficits in CM patients [31], and anti-tau immunotherapy prevented parasite-induced cognitive impairment and was associated with significantly reduced neuroinflammation and vascular congestion in ECM [32].